20
Ranbaxy Laboratories Limited Gurgaon In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Doxycycline hyclate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1997-002 - Rev 04
This Chemical Type CEP, issued on November 14, 2014, remains in force until March 24, 2015, ensuring its reliability within the pharmaceutical industry.
Substance Number 272 associated with this CEP further emphasizes